miR-200b precursor can ameliorate renal tubulointerstitial fibrosis.
miR-200b precursor can ameliorate renal tubulointerstitial fibrosis.
复制标题
DOI:
10.1371/journal.pone.0013614
复制
发表时间:
2010-10-25
期刊:
影响因子:
3.7
通讯作者:
Fujita T
中科院分区:
文献类型:
--
作者:
Oba S;Kumano S;Suzuki E;Nishimatsu H;Takahashi M;Takamori H;Kasuya M;Ogawa Y;Sato K;Kimura K;Homma Y;Hirata Y;Fujita T
Members of the miR-200 family of micro RNAs (miRNAs) have been shown to inhibit epithelial-mesenchymal transition (EMT). EMT of tubular epithelial cells is the mechanism by which renal fibroblasts are generated. Here we show that miR-200 family members inhibit transforming growth factor-beta (TGF-beta)-induced EMT of tubular cells. Unilateral ureter obstruction (UUO) is a common model of EMT of tubular cells and subsequent tubulointerstitial fibrosis. In order to examine the role of miR-200 family members in tubulointerstitial fibrosis, their expression was investigated in the kidneys of UUO mice. The expression of miR-200 family miRNAs was increased in a time-dependent manner, with induction of miR-200b most pronounced. To clarify the effect of miR-200b on tubulointerstitial fibrosis, we injected miR-200b precursor intravenously. A single injection of 0.5 nM miR-200b precursor was sufficient to inhibit the increase of collagen types I, III and fibronectin in obstructed kidneys, and amelioration of fibrosis was confirmed by observation of the kidneys with Azan staining. miR-200 family members have been previously shown to inhibit EMT by reducing the expression of ZEB-1 and ZEB-2 which are known repressors of E-cadherin. We demonstrated that expression of ZEB-1 and ZEB-2 was increased after ureter obstruction and that administration of the miR-200b precursor reversed this effect. In summary, these results indicate that miR-200 family is up-regulated after ureter obstruction, miR-200b being strongly induced, and that miR-200b ameliorates tubulointerstitial fibrosis in obstructed kidneys. We suggest that members of the miR-200 family, and miR-200b specifically, might constitute novel therapeutic targets in kidney disease.
登录
查看更多内容
影响因子:
14.9
作者:
Sun, YQ;Koo, S;Perera, RJ
通讯作者:
Perera, RJ
影响因子:
5
作者:
Kawai, Toru;Masaki, Takao;Yorioka, Noriaki
通讯作者:
Yorioka, Noriaki
DOI:
10.1016/j.bbrc.2008.04.097
发表时间:
2008-08-01
影响因子:
3.1
作者:
Mukai, Hidefumi;Kawakami, Shigeru;Hashida, Mitsuru
通讯作者:
Hashida, Mitsuru
影响因子:
11.2
作者:
Bracken, Cameron P.;Gregory, Philip A.;Goodall, Gregory J.
通讯作者:
Goodall, Gregory J.
影响因子:
13.2
作者:
KLAHR, S;ISHIDOYA, S;MORRISSEY, J
通讯作者:
MORRISSEY, J